GSK Rockville acquired Growth Direct™ in order to reduce the total bioburden assay time for water and CV samples with the intention of expanding the Growth Direct’s use to product related samples upon successful validation.
This informative poster outlines the studies performed by the GSK Rockville team in the validation of Growth Direct, including the determination of time to results.
RESULTS: The results collected thus far indicate the Growth Direct is capable of accurately enumerating microorganisms much earlier than are humanly visible.
Fill out the form to get instant access to this study.
